Bicara Therapeutics
BCAX • XNAS
Bicara Therapeutics is a pharmaceutical preparations company trading on XNAS, led by CEO Claire Mazumdar Clemon, with a market cap of $1.2B.
CEOClaire Mazumdar Clemon
Market Cap$1.2B
PHARMACEUTICAL PREPARATIONS
Next Earnings
Upcoming earnings announcement for Bicara Therapeutics
Date
Tuesday, May 12, 2026 (in a month)
Timing
Before Market Open (6:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.65
Earnings History
Past 6 earnings reports for Bicara Therapeutics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 30, 2026 | Q4 2025 | -$0.68Est: -$0.68 | 0.0% | — | — | — |
| Nov 10, 2025 | Q3 2025 | -$0.67Est: -$0.54 | -24.1% | - | — |  10-Q |
| Aug 12, 2025 | Q2 2025 | -$0.50Est: -$0.54 | +7.4% | - | — | 10-Q |
| May 13, 2025 | Q1 2025 | -$0.68Est: -$0.38 | -78.9% | - | — | 10-Q |
| Mar 27, 2025 | Q4 2024 | -$0.39Est: -$0.29 | -34.5% | - | — | 10-K |
| Nov 12, 2024 | Q3 2024 | -$1.60 | — | - | — | 10-Q |